In a filing, Protara Therapeutics Inc revealed its Chf Scientific Operations Off Zummo Jacqueline unloaded Company’s shares for reported $96145.0 on Mar 26 ’25. In the deal valued at $4.53 per share,21,224 shares were sold. As a result of this transaction, Zummo Jacqueline now holds 98,861 shares worth roughly $0.39 million.
Then, Zummo Jacqueline bought 21,224 shares, generating $96,569 in total proceeds.
Before that, Opaleye Management Inc. sold 126,301 shares. Protara Therapeutics Inc shares valued at $215,836 were divested by the 10% Owner at a price of $1.71 per share. As a result of the transaction, Opaleye Management Inc. now holds 45,000 shares, worth roughly $0.18 million.
Scotiabank initiated its Protara Therapeutics Inc [TARA] rating to a Sector outperform in a research note published on April 16, 2025; the price target was $12. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. H.C. Wainwright started covering the stock on June 04, 2021. It rated TARA as “a Buy”.
Price Performance Review of TARA
On Tuesday, Protara Therapeutics Inc [NASDAQ:TARA] saw its stock jump 2.34% to $3.94. Over the last five days, the stock has lost -4.83%. Protara Therapeutics Inc shares have fallen nearly -25.38% since the year began. Nevertheless, the stocks have risen 43.27% over the past one year. While a 52-week high of $10.48 was reached on 01/06/25, a 52-week low of $1.60 was recorded on 03/04/25. SMA at 50 days reached $4.05, while 200 days put it at $3.30.
Levels Of Support And Resistance For TARA Stock
The 24-hour chart illustrates a support level at 3.79, which if violated will result in even more drops to 3.64. On the upside, there is a resistance level at 4.08. A further resistance level may holdings at 4.22. The Relative Strength Index (RSI) on the 14-day chart is 46.46, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.39%. Stochastics %K at 35.68% indicates the stock is a holding.
How much short interest is there in Protara Therapeutics Inc?
A steep rise in short interest was recorded in Protara Therapeutics Inc stocks on 2025-03-31, dropping by -0.89 million shares to a total of 2.08 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 2.97 million shares. There was a decline of -42.52%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 17, 2021 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $43 price target.
